🇺🇸 FDA
Patent

US 8273729

Treatment of irritable bowel syndrome and related bowel disease

granted A61KA61K31/57A61P

Quick answer

US patent 8273729 (Treatment of irritable bowel syndrome and related bowel disease) held by The Board of Regents of the University of Texas System expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/57, A61P, A61P1/00